AI-generated summary
The authors randomized adults with subthreshold depression to bright light therapy or placebo for eight weeks and used resting-state brain imaging to study changes. They report that bright light therapy improved depressive symptoms and attention/vigilance, along with changes in cerebellar connectivity. They also report that baseline brain connectivity patterns were associated with attention improvement, but the abstract does not state the effect sizes or how the findings compare to placebo.
- Who or what was studied
- Individuals with subthreshold depression
- Limits stated in the abstract
- The abstract does not report effect sizes or between-group comparison results, so the strength of the findings is unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Depression, Randomized controlled trial, Bright light therapy, Biomarker. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.